Clinical benefits of precision medicine in treating solid cancers: European Society of Medical Oncology-Magnitude of Clinical Benefit Scale score-based analysis

BACKGROUND: Precision and matched cancer medicine has the potential to complement the existing biomarker approaches in cancer treatment. However, despite their promising potential, certain negative results have highlighted their limitations in molecular biology-driven treatment strategies. This stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Hibino, Y., Ito, M., Satake, T., Kondo, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207218/
https://www.ncbi.nlm.nih.gov/pubmed/34118770
http://dx.doi.org/10.1016/j.esmoop.2021.100187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207218/
https://www.ncbi.nlm.nih.gov/pubmed/34118770
http://dx.doi.org/10.1016/j.esmoop.2021.100187

Ejemplares similares